- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.44%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth and its peers as on 6 March, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth | 1.09% | -0.44% | -0.75% | 3% | 0.53% | 10.79% | 25.41% | 15.89% | - | - |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -6.88% | -0.48% | -2.33% | -2.98% | -7.15% | 0.58% | 13.01% | 15.94% | 15.17% | 15.96% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -5.68% | -1.18% | -3.5% | -3.99% | -6.28% | 8.33% | 13.66% | 11.75% | 13.69% | 13.62% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 2.01% | -0.09% | -0.62% | 4.31% | 0.05% | 8.52% | 27.17% | 18.41% | 21.54% | 13.29% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | -4.22% | -0.61% | -3.2% | -3.17% | -3.24% | 8.99% | 20.54% | 19.96% | 19.54% | 17.48% |
| SBI PSU Fund - DIRECT PLAN - GROWTH | 6.09% | -0.46% | -2.93% | 1.91% | 8.44% | 29.55% | 33.66% | 28.09% | 21.61% | 17.17% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | 57.54% | 20.14% | -11.24% | 40.42% | 37.69% | -3.36% |
Discrete returns (monthly)
| Month | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -0.46% | 3.21% | 3.96% | -0.38% | -1.79% | 1.3% | 0.44% | -1.25% | -3.8% | 4.81% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 12.33% | -1.41% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 96.74% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 3.26% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 11.60% |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 7.70% |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 6.68% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 4.56% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.55% |
| Abbott India Limited | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 4.43% |
| Torrent Pharmaceuticals Limited | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 4.30% |
| Ajanta Pharmaceuticals Limited | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 3.76% |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 3.30% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.97% |
| Mankind Pharma Ltd | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 2.83% |
| J.B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 2.80% |
| Emcure Pharmaceuticals Ltd | EMCURE (INE168P01015) | Pharmaceuticals & Biotechnology | 2.77% |
| Jupiter Life Line Hospitals Ltd | JLHL (INE682M01012) | Healthcare Services | 2.46% |
| Thyrocare Technologies Limited | THYROCARE (INE594H01019) | Healthcare Services | 2.28% |
| Alkem Laboratories Limited | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.28% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 2.07% |
| SAI Life Sciences Ltd | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.00% |
| ALEMBIC PHARMACEUTICALS LIMITED | APLLTD (INE901L01018) | Pharmaceuticals & Biotechnology | 1.96% |
| Shilpa Medicare Ltd | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 1.78% |
| Medi Assist Healthcare Services Ltd | MEDIASSIST (INE456Z01021) | Insurance | 1.76% |
| METROPOLIS HEALTHCARE LIMITED | METROPOLIS (INE112L01020) | Healthcare Services | 1.56% |
| ANTHEM BIOSCIENCES LIMITED | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 1.55% |
| Dr. Reddys Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 1.40% |
| Procter & Gamble Health Limited | PGHL (INE199A01012) | Pharmaceuticals & Biotechnology | 1.38% |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 1.27% |
| Suraksha Diagnostic Ltd | SURAKSHA (INE877V01027) | Healthcare Services | 1.26% |
| Jubilant Pharmova Ltd | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 1.23% |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.19% |
| Gland Pharma Limited | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.14% |
| SANOFI CONSUMER HEALTHCARE | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 1.09% |
| Piramal Pharma Ltd | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 1.04% |
| Pfizer Limited | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 1.01% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 0.95% |
| Vinati Organics Limited | VINATIORGA (INE410B01037) | Chemicals & Petrochemicals | 0.92% |
| Vijaya Diagnostic Centre Limited | VIJAYA (INE043W01024) | Healthcare Services | 0.91% |
Portfolio data is as on date 31 October, 2025
NAV history
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth - 30 days NAV (Net asset value) history
| Date | NAV |
|---|---|
| 6 March, 2026 | 34.3 |
| 5 March, 2026 | 34.45 |
| 4 March, 2026 | 34.08 |
| 2 March, 2026 | 34.44 |
| 27 February, 2026 | 34.56 |
| 26 February, 2026 | 34.94 |
| 25 February, 2026 | 34.64 |
| 24 February, 2026 | 34.23 |
| 23 February, 2026 | 34.2 |
| 20 February, 2026 | 33.88 |
| 19 February, 2026 | 33.91 |
| 18 February, 2026 | 34.12 |
| 17 February, 2026 | 34.14 |
| 16 February, 2026 | 33.99 |
| 13 February, 2026 | 33.73 |
| 12 February, 2026 | 33.98 |
| 11 February, 2026 | 34.06 |
| 10 February, 2026 | 33.86 |
| 9 February, 2026 | 33.81 |
| 6 February, 2026 | 33.3 |
| 5 February, 2026 | 33.33 |
| 4 February, 2026 | 33.33 |
| 3 February, 2026 | 33.46 |
| 2 February, 2026 | 32.64 |
| 30 January, 2026 | 32.86 |
| 29 January, 2026 | 32.36 |
| 28 January, 2026 | 32.65 |
| 27 January, 2026 | 32.64 |
| 23 January, 2026 | 32.61 |
| 22 January, 2026 | 32.99 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The latest NAV of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is 34.3 as on 6 March, 2026.What are YTD (year to date) returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The YTD (year to date) returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 1.09% as on 6 March, 2026.What are 1 year returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The 1 year returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 10.79% as on 6 March, 2026.What are 3 year CAGR returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The 3 year annualized returns (CAGR) of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 25.41% as on 6 March, 2026.What are 5 year CAGR returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The 5 year annualized returns (CAGR) of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 15.89% as on 6 March, 2026.